The Biopreservation Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
On the other hand, the high cost of medical instruments, including their initial purchase price and ongoing maintenance expenses, is a major factor that is expected to hinder the growth of the market. The high cost of medical instruments can make it difficult for healthcare providers and institutions to purchase and maintain these tools. The cost of purchasing advanced and specialized instruments can be quite high, and the cost of maintaining and repairing these instruments can also add up over time. This financial burden can limit the adoption and usage of these instruments, which can in turn slow down the growth of the market.
Additionally, there is a risk of tissue injury during the preservation, which can also lead to negative outcomes and potentially harm the market growth. These factors combined are likely to challenge market growth over the forecast period.
Upsurge in R&D and Product Development to Bolster Market Growth
The companies operating in the biopreservation market, research associations, and non- governmental organizations, among other stakeholders, are focused on increasing their efforts in research and development of innovative techniques in the field of biopreservation industry. For instance, in November 2021, Spain was formally recognised as a new Observer in the European research infrastructure partnership BBMRI- ERIC (Biobanks and Biomolecular Resources Research Infrastructure Consortium), with an emphasis on biobanking and biomolecular research.On the other hand, the high cost of medical instruments, including their initial purchase price and ongoing maintenance expenses, is a major factor that is expected to hinder the growth of the market. The high cost of medical instruments can make it difficult for healthcare providers and institutions to purchase and maintain these tools. The cost of purchasing advanced and specialized instruments can be quite high, and the cost of maintaining and repairing these instruments can also add up over time. This financial burden can limit the adoption and usage of these instruments, which can in turn slow down the growth of the market.
Additionally, there is a risk of tissue injury during the preservation, which can also lead to negative outcomes and potentially harm the market growth. These factors combined are likely to challenge market growth over the forecast period.
Lack of Efficient Temperate Control Could Impede Industry Development
One of the main challenges for the development of new storage technologies is the need to maintain and regulate the room temperature storage. For instance, vaccines save almost 3 million lives each year in the United States, but due to improper refrigeration and storage, vaccines worth about US$20 million are lost or abandoned each year. The frequent tissue or cell injury that results from freezing and thawing is impeding market revenue. Nevertheless, future market projections will be driven by continuous research into the durability of products like genes, vaccines, and other bio preserved products.What Questions Should You Ask before Buying a Market Research Report?
- How is the Biopreservation Market evolving?
- What is driving and restraining the Biopreservation Market?
- How will each Biopreservation submarket grow over the forecast period and how much revenue will these submarkets account for in 2033?
- How will the market shares for each Biopreservation submarket develop from 2023 to 2033?
- What will be the main driver for the overall market from 2023 to 2033?
- Will leading Biopreservation Markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
- How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
- Who are the leading players and what are their prospects over the forecast period?
- What are the Biopreservation product development projects for these leading companies?
- How will the industry evolve during the period between 2023 and 2033? What are the implications of Biopreservation product development projects taking place now and over the next 10 years?
- Is there a greater need for product commercialisation to further scale the Biopreservation Market?
- Where is the Biopreservation Market heading and how can you ensure you are at the forefront of the market?
- What are the best investment options for new product and service lines?
- What are the key prospects for moving companies into a new growth path and C- suite?
You need to discover how this will impact the Biopreservation Market today, and over the next 10 years:
- Our 277- page report provides 115 tables and 174 charts/graphs exclusively to you.
- The report highlights key lucrative areas in the industry so you can target them - NOW.
- It contains in- depth analysis of global, regional and national sales and growth.
- It highlights for you the key successful trends, changes and revenue projections made by your competitors.
Forecasts to 2033 and other analyses reveal commercial prospects
- In addition to revenue forecasting to 2033, the new study provides you with recent results, growth rates, and market shares.
- You will find original analyses, with business outlooks and developments.
- Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising biopreservation product prices and recent developments.
Segments Covered in the Report
By Product
- Equipment
- Freezers
- Refrigerators
- Consumables
- Liquid Nitrogen
- Media
- Pre- formulated
- Home- brew
- Laboratory Information Management Systems (LIMS)
By Application
- Regenerative Medicine
- Cell Therapy
- Gene Therapy
- Others
- Biobanking
- Human Eggs
- Human Sperm
- Veterinary IVF
- Drug Discovery
By Cell Provider
- CD34+
- CD19+
- MSC
- iPSC
- hESC
- Tumour cells
- Others
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
MEA
- GCC
- South Africa
- Rest of MEA
Leading companies and the potential for market growth
- Arctiko
- Azenta
- BioLife Solutions Inc.
- Biomatrica
- Cryoport Systems, LLC
- Eppendorf SE
- Helmer Scientific Inc.
- Merck KGaA
- PHC Holdings Corporation
- Qiagen
- Taylor- Wharton Cryogenics LLC
- Thermo Fisher Scientific Inc.
- VWR International
How will the Biopreservation Market, 2023 to 2033 report help you?
In summary, this 270+ page report provides you with the following knowledge:- Revenue forecasts to 2033 for Biopreservation Market, 2023 to 2033 Market, with forecasts for Type of Product, Type of Application, Type of Cell provider, each forecast at a global and regional level - discover the industry’s prospects, finding the most lucrative places for investments and revenues.
- Revenue forecasts to 2033 for five regional and 16 key national markets - See forecasts for the Biopreservation Market, 2023 to 2033 market in North America, Europe, Asia-Pacific and Latin America and Middle East and Africa. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
- Prospects for established firms and those seeking to enter the market - including company profiles of the major companies involved in the Biopreservation Market, 2023 to 2033.
Information found nowhere else
With this new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how this work could benefit your research, analyses, and decisions. The study is for everybody needing commercial analyses for the Biopreservation Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.Table of Contents
1 Report Overview
3 Market Overview
4 Biopreservation Market Analysis by Product
5 Biopreservation Market Analysis by Application
6 Biopreservation Market Analysis by Cell Provider
7 Biopreservation Market Analysis by Region
8 North America Biopreservation Market Analysis
9 Europe Biopreservation Market Analysis
10 Asia Pacific Biopreservation Market Analysis
11 Latin America Biopreservation Market Analysis
12 MEA Biopreservation Market Analysis
13 Company Profiles
14 Conclusion and Recommendations
Companies Mentioned
- Arctiko
- Azenta
- BioLife Solutions Inc.
- Biomatrica
- Cryoport Systems, LLC
- Eppendorf SE
- Helmer Scientific Inc.
- Merck KGaA
- PHC Holdings Corporation
- Qiagen
- Taylor-Wharton Cryogenics LLC
- Thermo Fisher Scientific Inc.
- VWR International
- Astellas Pharma Inc.
- B Medical Systems
- Cell&Co BioServices
- CSafe
- Inception Fertility
- Koki Holdings Co., Ltd.
- Pantherna Therapeutics GmbH
- Rhinostics
- RURO Inc.
- SciSafe
- Sexton Biotechnologies
- Stirling Ultracold
- Syneos Health
- Trans-Hit Biomarkers Inc.
- Biobanca Multispecialista (BMS)
- Biobanks and Biomolecular Resources Research Infrastructure Consortium
- Biobanks South Africa (BBSA)
- British Heart Foundation
- Cancer Research UK
- Chinese Maternal and Child Health Association
- Fertility Preservation Professional Committee
- German Biobank Alliance (GBA)
- German Biobank Node (GBN)
- Groupe de Recherche et d'Etude sur la Conservation Ovarienne et Testiculaire (GRECOT)
- Italian Research Infrastructure for Sustainable Bioscience and Bioeconomy (IRISBB)
- National Cancer Institute (NCI)
- National Institute for Health and Care Research
- National Institutes of Health (NIH)
- National Irish COVID-19 Biobank (NICB)
- Qatar Biobank
- South African Department of Science and Innovation (DSI)
- Stem Cell Network
- The Fundación Instituto Valenciano de Oncologa (IVO Biobank)
- The Israeli Fertility Society (ILA)
- The National Institute for Health Research (NIHR)
- U.S. Food and Drug Administration (U.S.FDA)
- U.S. Department of Health and Human Services (HHS)
- UK Biobank
- World Health Organization (WHO)